CBD Co. Execs Can't Rewrite Admissions, Investor Says
Executives of a CBD company shouldn't be allowed to take back admissions they already made, an investor in the company told a Nevada federal judge in regards to his case against...To view the full article, register now.
Already a subscriber? Click here to view full article